Description
GALAFOLD
First action · last action
2024-11-13 · 2025-08-08
Transactions
3
First transaction's obligation
$253,074
Base + all options value (sum of deltas)
$304,873
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79724D0185
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-11-13+$253,074= $253,074
- Mod P000012025-01-22+$8,017= $261,091
- Mod P000022025-08-08+$43,782= $304,873
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-11-13 | +$253,074 | $253,074 | GALAFOLD |
| Mod P00001· FUNDING ONLY ACTION | 2025-01-22 | +$8,017 | $261,091 | GALAFOLD |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-08-08 | +$43,782 | $304,873 | GALAFOLD |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KLJFGENKMD89)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0676 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $68,519 | FY2026 |
| 36C24526F0342 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,840 | FY2026 |
| 36C24526N0706 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,840 | FY2026 |
| 36C24526N0621 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,840 | FY2026 |
| 36C24926F0155 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $68,519 | FY2026 |
| 36C26126F0214 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $22,840 | FY2026 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926F0310 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0409 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $34,735 | FY2026 |
| 36C25926F0264 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0384 | SIRTEX MEDICAL INC | NETWORK CONTRACT OFFICE 19 (36C259) | $245,194 | FY2026 |
| 36C25926P0553 | COSETTE PHARMACEUTICALS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $3,439 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25925F0067_3600_36F79724D0185_3600 · retrieved 2026-09-26.